A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer.
Qin Y, Zu X, Li Y, Han Y, Tan J, Cai C, Shen E, Liu P, Deng G, Feng Z, Wu W, Peng Y, Liu Y, Ma J, Zeng S, Chen Y, Shen H.
Qin Y, et al. Among authors: tan j.
iScience. 2023 Aug 25;26(9):107722. doi: 10.1016/j.isci.2023.107722. eCollection 2023 Sep 15.
iScience. 2023.
PMID: 37694141
Free PMC article.